Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
Globus Medical (NYSE: GMED) has unveiled DuraPro™, a next-generation oscillating system with enhanced navigation capabilities through its Excelsius™ platform. The system aims to disrupt the $550 million high-speed drill market with innovative technology designed to protect delicate tissue during surgical procedures.
DuraPro™'s key features include anti-skiving pilot hole drilling, brush attachments for thorough discectomies, and seamless integration with ExcelsiusGPS™ and ExcelsiusHub™. The company also launched Verzera™, a navigated high-speed drill system, expanding their Power Portfolio of surgical solutions.
Globus Medical (NYSE: GMED) ha presentato DuraPro™, un sistema oscillante di nuova generazione con capacità di navigazione avanzate tramite la piattaforma Excelsius™. Questo sistema punta a rivoluzionare il mercato delle frese ad alta velocità da 550 milioni di dollari grazie a una tecnologia innovativa progettata per proteggere i tessuti delicati durante gli interventi chirurgici.
Le caratteristiche principali di DuraPro™ includono la perforazione del foro pilota anti-skiving, accessori a spazzola per discectomie approfondite e un’integrazione fluida con ExcelsiusGPS™ ed ExcelsiusHub™. L’azienda ha inoltre lanciato Verzera™, un sistema di fresa ad alta velocità navigato, ampliando così il proprio Power Portfolio di soluzioni chirurgiche.
Globus Medical (NYSE: GMED) ha presentado DuraPro™, un sistema oscilante de última generación con capacidades mejoradas de navegación a través de su plataforma Excelsius™. El sistema busca revolucionar el mercado de taladros de alta velocidad de 550 millones de dólares con una tecnología innovadora diseñada para proteger los tejidos delicados durante procedimientos quirúrgicos.
Las características principales de DuraPro™ incluyen perforación de orificios piloto anti-skiving, accesorios de cepillo para discectomías completas y una integración perfecta con ExcelsiusGPS™ y ExcelsiusHub™. La compañía también lanzó Verzera™, un sistema de taladro de alta velocidad con navegación, ampliando su Power Portfolio de soluciones quirúrgicas.
Globus Medical (NYSE: GMED)는 Excelsius™ 플랫폼을 통한 향상된 내비게이션 기능을 갖춘 차세대 진동 시스템인 DuraPro™를 공개했습니다. 이 시스템은 수술 중 섬세한 조직을 보호하도록 설계된 혁신적인 기술로 5억 5천만 달러 규모의 고속 드릴 시장을 혁신하는 것을 목표로 합니다.
DuraPro™의 주요 기능으로는 스키빙 방지 파일럿 홀 드릴링, 철저한 디섹토미를 위한 브러시 부착물, ExcelsiusGPS™ 및 ExcelsiusHub™와의 원활한 통합이 포함됩니다. 또한 회사는 내비게이션 기능이 탑재된 고속 드릴 시스템인 Verzera™를 출시하여 수술 솔루션의 Power Portfolio를 확장했습니다.
Globus Medical (NYSE : GMED) a dévoilé DuraPro™, un système oscillant de nouvelle génération doté de capacités de navigation améliorées via sa plateforme Excelsius™. Ce système vise à révolutionner le marché des forets haute vitesse de 550 millions de dollars grâce à une technologie innovante conçue pour protéger les tissus délicats lors des interventions chirurgicales.
Les caractéristiques clés de DuraPro™ incluent un forage de trou pilote anti-skiving, des accessoires brosse pour des discectomies approfondies, ainsi qu’une intégration fluide avec ExcelsiusGPS™ et ExcelsiusHub™. La société a également lancé Verzera™, un système de foret haute vitesse navigué, élargissant ainsi son Power Portfolio de solutions chirurgicales.
Globus Medical (NYSE: GMED) hat DuraPro™ vorgestellt, ein neuartiges oszillierendes System mit erweiterten Navigationsfunktionen über seine Excelsius™-Plattform. Das System zielt darauf ab, den 550-Millionen-Dollar-Markt für Hochgeschwindigkeitsbohrer mit innovativer Technologie zu revolutionieren, die empfindliches Gewebe während chirurgischer Eingriffe schützt.
Zu den Hauptmerkmalen von DuraPro™ gehören das Anti-Skiving-Pilotlochbohren, Bürstenaufsätze für gründliche Diskektomien und die nahtlose Integration mit ExcelsiusGPS™ und ExcelsiusHub™. Das Unternehmen hat außerdem Verzera™ eingeführt, ein navigiertes Hochgeschwindigkeitsbohrsystem, und erweitert damit sein Power Portfolio chirurgischer Lösungen.
- Targeting a substantial $550 million market opportunity in high-speed drills
- Advanced safety features including tissue protection and anti-skiving technology
- Integration with existing ExcelsiusGPS and ExcelsiusHub platforms enhances product ecosystem
- Expansion of Power Portfolio with both DuraPro and Verzera systems
- Significant competition in the surgical equipment market
- Integration risks with NuVasive and Nevro businesses mentioned in forward-looking statements
Insights
Globus Medical's DuraPro navigation system targets $550M drill market with tissue-protective technology that could strengthen competitive position.
Globus Medical has launched an enhanced version of its DuraPro oscillating system with navigation capabilities, representing a strategic move to capture share in the
The system's key differentiation lies in its oscillating technology that helps protect delicate neural tissues while efficiently cutting bone. This positions it as potentially safer than traditional spinning drills that risk tissue wrapping. The technical highlights include anti-skiving pilot hole drilling that maintains trajectory and brush attachments for thorough discectomies.
Most significantly, DuraPro integrates with Globus Medical's ExcelsiusGPS and ExcelsiusHub platforms, creating a comprehensive procedural solution that combines navigation precision with tissue protection. This integration demonstrates Globus Medical's platform strategy of building an ecosystem of complementary surgical technologies.
Alongside DuraPro, the company introduced Verzera, a navigated high-speed drill system that further expands their power instruments portfolio. Together, these launches represent Globus Medical's continued investment in its enabling technologies segment, which complements their core spine implant business.
The clinical validation from surgeons at Axis Spine Center provides important third-party credibility, noting increased confidence during delicate decompressions. This technology advancement addresses surgeon concerns about inadvertent tissue damage during bone removal procedures, potentially reducing complications and improving procedural efficiency.
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency.
“Our goal is to revolutionize the
With its cutting-edge oscillating technology, DuraPro™ helps prevent soft tissue wrapping while retaining a natural sensation akin to that of conventional spinning drills. This system provides surgeons with instruments for efficient, accurate cutting to remove bone, while utilizing oscillating technology to help safeguard delicate tissue. It also features anti-skiving pilot hole drilling; the oscillating nature of the technology allows for drill tips to maintain trajectories without deviating from the starting point, and the brush attachments facilitate thorough discectomies. The versatile system seamlessly integrates with ExcelsiusGPS™ and ExcelsiusHub™ to support accuracy, efficiency and confidence across navigated and non-navigated workflows.
“DuraPro™ allows us to navigate around delicate structures with greater confidence during decompressions,” share Drs. Roland Kent and David Glassman of Axis Spine Center in Cour D’Alene, Idaho. “The integration with ExcelsiusGPS™ takes it a step further—providing real-time visualization for accuracy while reinforcing the safety benefits of oscillating technology.”
In addition to DuraPro™, Globus Medical launched Verzera™, a navigated high-speed drill system integrated with the ExcelsiusGPS and ExcelsiusHub system. Verzera™ augments existing workflows for surgeons utilizing Globus’ enabling technologies, by allowing them to navigate bone removal during procedures.
The expanded Globus Medical Power Portfolio represents the Company’s continued commitment to solving unmet clinical needs and delivering surgeons with added confidence through procedurally integrated technology. Learn more about the Power Portfolio here.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and achieve anticipated synergies with the integration, health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of Globus Medical contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
What is the market size for Globus Medical's DuraPro high-speed drill system?
What are the key features of Globus Medical's DuraPro system?
How does DuraPro integrate with Globus Medical's existing technology?
What products were included in Globus Medical's Power Portfolio announcement?
How does GMED's DuraPro technology improve surgical safety?
